Crushing Pulmonology: 5 Essential Concepts for FNP Board Success
Pulmonology · 6 min read · June 18, 2026
The respiratory system is a cornerstone of family nurse practitioner practice, and you can bet it will be well-represented on your FNP board exams. Don't let the breadth of pulmonology overwhelm you. Instead, let's focus on the high-yield topics that are most likely to appear, ensuring you're prepared to confidently answer those challenging questions.
Asthma: Understanding the Inflammatory Airway
Asthma is a chronic inflammatory disorder of the airways characterized by recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or in the early morning. It's crucial to understand both its pathophysiology and management.
Pathophysiology: Think of asthma as a triad: inflammation, bronchoconstriction, and airway hyperresponsiveness. Triggers (allergens, exercise, cold air, infections) cause mast cell degranulation and release of inflammatory mediators, leading to smooth muscle contraction and increased mucus production.
Diagnosis: Primarily clinical, based on symptoms and spirometry. A significant improvement in FEV1 (forced expiratory volume in 1 second) after bronchodilator administration (e.g., albuterol) is diagnostic. A >12% and 200 mL increase in FEV1 is considered reversible airflow obstruction.
Management: The cornerstone of chronic management is inhaled corticosteroids (ICS), which address the underlying inflammation. Short-acting beta-agonists (SABAs) like albuterol are for quick relief of symptoms. Long-acting beta-agonists (LABAs) are never used alone in asthma; they are always combined with an ICS.
Clinical Pearl: Remember the stepwise approach to asthma management. If a patient is using their SABA more than twice a week (not for exercise-induced asthma), their asthma is not well-controlled, and you need to step up their therapy. Always assess inhaler technique!
COPD: Chronic Obstructive Pulmonary Disease
COPD is a progressive, irreversible airflow limitation, primarily caused by exposure to noxious particles or gases, most commonly cigarette smoking. It encompasses two main conditions: chronic bronchitis and emphysema.
Chronic Bronchitis: Defined clinically by a chronic productive cough for at least three months a year for two consecutive years. It involves inflammation and mucus hypersecretion in the large airways.
Emphysema: Defined pathologically by permanent enlargement of the airspaces distal to the terminal bronchioles, with destruction of their walls without obvious fibrosis. This leads to decreased elastic recoil and air trapping.
Diagnosis: Confirmed by spirometry showing a post-bronchodilator FEV1/FVC ratio < 0.70. This irreversible airflow obstruction is key. Unlike asthma, the obstruction is not fully reversible.
Management: Smoking cessation is the single most important intervention. Pharmacotherapy focuses on symptom relief and reducing exacerbations. Bronchodilators (long-acting muscarinic antagonists - LAMAs, and long-acting beta-agonists - LABAs) are the mainstay. Inhaled corticosteroids are reserved for patients with frequent exacerbations or significant eosinophilia.
Board Tip: Recognize the classic presentations: "blue bloaters" (chronic bronchitis – cyanosis, edema, productive cough) vs. "pink puffers" (emphysema – thin, barrel chest, pursed-lip breathing, dyspnea). While these are stereotypes, they help differentiate the primary pathology.
Pneumonia: Identifying and Treating Lung Infections
Pneumonia is an acute infection of the lung parenchyma. It's a common and potentially serious condition that FNPs frequently encounter.
Etiology: Community-acquired pneumonia (CAP) is most often caused by Streptococcus pneumoniae (the most common bacterial cause), Mycoplasma pneumoniae, Chlamydophila pneumoniae, and viruses (influenza, RSV). Hospital-acquired pneumonia (HAP) involves different, often more resistant, pathogens.
Clinical Presentation: Fever, chills, productive cough (purulent sputum), dyspnea, pleuritic chest pain. On physical exam, you might hear rales/crackles and dullness to percussion over the affected lobe.
Diagnosis: Chest X-ray showing infiltrates is essential for diagnosis. Sputum cultures are often not routinely done in outpatient CAP unless initial therapy fails or there are specific risk factors.
Management: Empiric antibiotic therapy is initiated based on patient age, comorbidities, and local resistance patterns. For healthy outpatients, a macrolide (e.g., azithromycin) or doxycycline is often first-line. For those with comorbidities or recent antibiotic use, a respiratory fluoroquinolone (e.g., levofloxacin) or a beta-lactam plus a macrolide is appropriate.
Clinical Pearl: Always consider the CURB-65 score for pneumonia to assess severity and guide admission decisions. Confusion, Urea > 7 mmol/L, Respiratory rate > 30 bpm, Blood pressure (systolic < 90 mmHg or diastolic < 60 mmHg), Age ≥ 65 years. Each factor is worth one point. 0-1 points: outpatient; 2 points: consider inpatient; 3-5 points: severe pneumonia, consider ICU.
Tuberculosis (TB): The Resurgent Threat
TB, caused by Mycobacterium tuberculosis, remains a global health concern. It's critical to understand its latent and active forms.
Latent TB Infection (LTBI): The bacteria are present but inactive. The patient is asymptomatic, non-infectious, and has a positive TB skin test (TST) or interferon-gamma release assay (IGRA). Treatment is given to prevent progression to active disease.
Active TB Disease: The bacteria are multiplying and causing symptoms. The patient is symptomatic (cough, fever, night sweats, weight loss), often infectious, and has a positive TST/IGRA, positive sputum smear/culture, and chest X-ray abnormalities (e.g., apical infiltrates).
Diagnosis: TST or IGRA for screening. For active disease, sputum acid-fast bacilli (AFB) smear and culture are definitive. Chest X-ray helps localize the disease.
Management: Active TB requires a multi-drug regimen (often 4 drugs: isoniazid, rifampin, pyrazinamide, ethambutol) for an extended period (6-9 months). LTBI is typically treated with isoniazid for 6-9 months or rifampin for 4 months.
Board Tip: Remember that a positive TST does not differentiate between latent and active TB. Further workup (symptoms, chest X-ray, sputum) is needed to rule out active disease before treating for LTBI.
Pulmonary Embolism (PE): The Silent Killer
PE is a life-threatening condition caused by a blockage in one of the pulmonary arteries, usually by a blood clot (thrombus) that has traveled from elsewhere in the body (most often the deep veins of the legs – DVT).
Risk Factors: The classic Virchow's Triad: venous stasis (immobility, surgery, long travel), endothelial injury (trauma, surgery), and hypercoagulability (malignancy, oral contraceptives, inherited thrombophilias).
Clinical Presentation: Highly variable and non-specific. Common symptoms include sudden onset dyspnea, pleuritic chest pain, cough, and sometimes hemoptysis. Tachycardia and tachypnea are common physical exam findings. Hypoxia may be present.
Diagnosis: Initial evaluation often includes a D-dimer (useful for ruling out PE in low-risk patients – a negative D-dimer makes PE highly unlikely). The gold standard for diagnosis is a CT pulmonary angiography (CTPA). V/Q scan is an alternative if CTPA is contraindicated.
Management: Anticoagulation is the cornerstone of treatment, usually with heparin (LMWH or unfractionated) followed by an oral anticoagulant (warfarin or a direct oral anticoagulant – DOAC) for at least 3-6 months. Thrombolysis or embolectomy may be considered in massive PE with hemodynamic instability.
Clinical Pearl: Don't underestimate the power of a good history and risk factor assessment. If a patient presents with sudden dyspnea and pleuritic chest pain, especially with risk factors, PE should be high on your differential. A negative D-dimer in a low-probability patient can save them from unnecessary imaging.
Your Journey to FNP Success
Pulmonology might seem daunting, but by focusing on these high-yield topics and understanding the core principles of diagnosis and management, you're building a strong foundation for your FNP boards. Remember, every question you answer correctly is a step closer to your goal. Keep reviewing, keep practicing, and trust in the knowledge you've gained. You've got this!
Ready to elevate your board prep? Visit store.thefnpreview.com for comprehensive study materials and practice questions designed to help you ace your FNP exams.